Emerging data from high and upper middle income countries indicate that suicide rates generally did not increase during the initial months of the COVID-19 pandemic, yet the pandemic's impact on suicide is complex. We discuss the nuances of this relationship, how it may evolve over time, and describe the specific steps that governments and societies must take to mitigate harm and prevent suicides in the late stages and aftermath of the pandemic.
Bibliographical noteFunding Information:
Affiliations of the International COVID-19 Suicide Prevention Research Collaboration are listed in the Supplementary Appendix . MS has received salary support from Academic Scholar Awards from the Departments of Psychiatry at the University of Toronto and Sunnybrook Health Sciences Centre. MS has grants from the American Foundation for Suicide Prevention, the Canadian Institutes of Health Research, the Ontario Ministry of Research and Innovation, Mental Health Research Canada, the Institute for the Advancements in Mental Health, the University of Toronto Miner’s Lamp Innovation Fund, and Telus Canada. DK is supported by the Elizabeth Blackwell Institute for Health Research, University of Bristol and the Wellcome Trust Institutional Strategic Support Fund (ISSF3: 204813/Z/16/Z). MRP is supported in part by the National Natural Science Foundation of China (NSFC, 81761128031). DG is a member of the Department of Health and Social Care (England) National Suicide Prevention Strategy Advisory Group. DG is supported by the NIHR Biomedical Research Centre at University Hospitals Bristoland Weston NHS Foundation Trust and the University of Bristol, UK. DG has grants from the National Institute for Health Research (NIHR) outside the submitted work and is a member of the Samaritans Policy and Research Committee and Movember’s Global Advisory Committee. All other authors declare no competing interests.
© 2021 The Author(s). Published with license by Taylor & Francis Group, LLC.
- International COVID-19 Suicide Prevention Research Collaboration